Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney
Volume: 30, Issue: 6, Pages: 1162 - 1166
Published: Aug 1, 2016
Abstract
Diabetic ketoacidosis is a serious metabolic condition that may occur in patients with either Type 1 or Type 2 diabetes. The accumulation of ketoacids in the serum is a consequence of insulin deficiency and glucagon excess. Sodium Glucose Transporter 2 (SGLT2) inhibitors are novel therapeutic treatments for improving glucose homeostasis in patients with diabetes. Through reductions in glucose reabsorption by the kidney, they lower serum glucose...
Paper Details
Title
Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney
Published Date
Aug 1, 2016
Volume
30
Issue
6
Pages
1162 - 1166
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History